Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

KRX:185750 Revenue

Chong Kun Dang Pharmaceutical had revenue of 434.85B KRW in the quarter ending June 30, 2025, with 9.59% growth. This brings the company's revenue in the last twelve months to 1.66T, down -0.16% year-over-year. In the year 2024, Chong Kun Dang Pharmaceutical had annual revenue of 1.59T, down -4.97%.

• Revenue (ttm): 1.66T
• Revenue Growth: -0.16%
• P/S Ratio: 0.65
• Revenue / Employee: 738.54M
• Employees: 2,253
• Market Cap: 1.09T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.59T	-82.97B	-4.97%
Dec 31, 2023	1.67T	181.06B	12.17%
Dec 31, 2022	1.49T	144.79B	10.78%
Dec 31, 2021	1.34T	40.55B	3.11%
Dec 31, 2020	1.30T	223.67B	20.72%